Gastric cancer is the fourth most common malignancy and the third leading cause of cancer-
related deaths worldwide. Advanced gastric cancer patients can notably benefit from …

Gastric cancer (GC) is the third leading cause of cancer-related deaths worldwide, with high
recurrence and mortality rate. Chemotherapy, including 5-fluorouracil (5-FU), adriamycin …

Non-coding RNAs (ncRNAs) have recently become increasingly important in the study of
cellular metabolism and regulation such as development, proliferation, differentiation and …

Gastric cancer is a deadly disease and remains the third leading cause of cancer-related
death worldwide. The 5-year overall survival rate of patients with early-stage localized …

Gastric cancer (GC) is one of the most common malignant tumors of digestive systems
worldwide, with high recurrence and mortality. Chemotherapy is still the standard treatment …

Gastric cancer (GC) is one of the most prevalent malignant tumor types and the third leading
cause of cancer-related death worldwide. Its morbidity and mortality are very high due to a …

Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a
serious, long-term threat to patients' health and life. Systemic chemotherapy remains the first …

Long non-coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides. Recent
advances in the non-protein coding part of human genome analysis have discovered …

Gastric cancer (GC) is currently the fourth most common malignancy and the third leading
cause of cancer-related deaths worldwide. Long non-coding RNAs (lncRNAs) …

Long noncoding RNAs (lncRNAs) recently have been recognized as having a critical role in
cancer development and progression. Gastric cancer remains a major clinical challenge …